Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease.
作者信息
Han Eugene
机构信息
Division of Endocrinology and Metabolism, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea.
出版信息
Diabetes Metab J. 2022 Jul;46(4):564-566. doi: 10.4093/dmj.2022.0203. Epub 2022 Jul 27.
Abstract
摘要
相似文献
1
Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease.肝病之外：非酒精性脂肪性肝病与肾病中的晚期肝纤维化
Diabetes Metab J. 2022 Jul;46(4):564-566. doi: 10.4093/dmj.2022.0203. Epub 2022 Jul 27.
2
Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis.非酒精性脂肪性肝病中肌肉减少症与脂肪性肝炎及晚期肝纤维化的关系：一项荟萃分析
BMC Gastroenterol. 2018 Apr 19;18(1):51. doi: 10.1186/s12876-018-0776-0.
3
Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease.糖尿病影响非酒精性脂肪性肝病患者非侵入性纤维化模型对肝硬化和预后的预测。
Liver Int. 2018 Oct;38(10):1793-1802. doi: 10.1111/liv.13739. Epub 2018 Mar 31.
4
Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease.前瞻性评估非酒精性脂肪性肝病患者的初级保健转诊途径。
J Hepatol. 2019 Aug;71(2):371-378. doi: 10.1016/j.jhep.2019.03.033. Epub 2019 Apr 6.
5
Defining characteristics and outcomes for patients with non-alcoholic fatty liver disease admitted to hospital with decompensated cirrhosis.因失代偿期肝硬化入院的非酒精性脂肪性肝病患者的定义特征和结局
J Hepatol. 2023 Oct;79(4):e165-e167. doi: 10.1016/j.jhep.2023.05.035. Epub 2023 Jun 12.
6
Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.非酒精性脂肪性肝病中的肝纤维化——具有预后意义的诊断挑战
World J Gastroenterol. 2015 Oct 21;21(39):11077-87. doi: 10.3748/wjg.v21.i39.11077.
7
Is ultrasonography-diagnosed nonalcoholic fatty liver disease fibrosis score associated with the Framingham risk score?超声诊断的非酒精性脂肪性肝病纤维化评分与弗雷明汉风险评分相关吗？
Eur J Gastroenterol Hepatol. 2015 Jun;27(6):748-9. doi: 10.1097/MEG.0000000000000345.
8
Reply to: "Possible link between higher ammonia levels, non-alcoholic fatty liver-related cirrhosis and diabetes: Are we missing chronic kidney disease?".回复：“高氨水平、非酒精性脂肪性肝病相关肝硬化与糖尿病之间的潜在联系：我们是否忽略了慢性肾脏病？”
J Hepatol. 2023 Feb;78(2):e73-e74. doi: 10.1016/j.jhep.2022.10.024. Epub 2022 Nov 1.
9
Low vitamin D status is associated with advanced liver fibrosis in patients with nonalcoholic fatty liver disease.维生素D水平低与非酒精性脂肪性肝病患者的晚期肝纤维化有关。
Endocrine. 2017 Feb;55(2):582-590. doi: 10.1007/s12020-016-1152-x. Epub 2016 Oct 31.
10
Diagnostic value of MRI-derived liver surface nodularity score for the non-invasive quantification of hepatic fibrosis in non-alcoholic fatty liver disease.MRI衍生的肝脏表面结节评分对非酒精性脂肪性肝病肝纤维化无创定量的诊断价值
Eur Radiol. 2021 Jan;31(1):256-263. doi: 10.1007/s00330-020-07114-y. Epub 2020 Aug 5.
引用本文的文献
1
From Liver to Kidney: The Overlooked Burden of Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease.从肝脏到肾脏：慢性肾脏病中非酒精性脂肪性肝病被忽视的负担
J Clin Med. 2025 Apr 5;14(7):2486. doi: 10.3390/jcm14072486.
本文引用的文献
1
Changes in the prevalence of hepatitis B and metabolic abnormalities among young men in Korea.韩国年轻男性中乙型肝炎患病率及代谢异常情况的变化
Korean J Intern Med. 2022 Sep;37(5):1082-1087. doi: 10.3904/kjim.2021.452. Epub 2022 May 13.
2
Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.在2型糖尿病和非酒精性脂肪性肝病患者中，晚期肝纤维化与慢性肾脏病相关。
Diabetes Metab J. 2022 Jul;46(4):630-639. doi: 10.4093/dmj.2021.0130. Epub 2022 Jan 26.
3
Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.白蛋白尿与 2 型糖尿病和非酒精性脂肪性肝病患者的脂肪变性负担相关。
Diabetes Metab J. 2021 Sep;45(5):698-707. doi: 10.4093/dmj.2020.0118. Epub 2021 Feb 2.
4
Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes.在韩国2型糖尿病患者中，肝纤维化与总蛋白尿有关。
Medicine (Baltimore). 2020 Aug 14;99(33):e21038. doi: 10.1097/MD.0000000000021038.
5
Trends in the prevalence of chronic liver disease in the Korean adult population, 1998-2017.1998 - 2017年韩国成年人群慢性肝病患病率趋势
Clin Mol Hepatol. 2020 Apr;26(2):209-215. doi: 10.3350/cmh.2019.0065. Epub 2019 Nov 4.
6
Association between nonalbumin proteinuria and renal tubular damage of N-acetyl-β-d-glucosaminidase and its clinical relevance in patients with type 2 diabetes without albuminuria.2 型糖尿病患者非白蛋白尿与 N-乙酰-β-D-氨基葡萄糖苷酶的肾小管损伤及其临床相关性
J Diabetes Complications. 2019 Mar;33(3):255-260. doi: 10.1016/j.jdiacomp.2018.09.010. Epub 2018 Sep 15.
7
Nonalcoholic fatty liver disease and albuminuria: a systematic review and meta-analysis.非酒精性脂肪性肝病与蛋白尿：一项系统评价和荟萃分析。
Eur J Gastroenterol Hepatol. 2018 Sep;30(9):986-994. doi: 10.1097/MEG.0000000000001169.
8
Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study.非酒精性脂肪性肝病加速慢性肾脏病患者肾功能下降：一项队列研究。
Sci Rep. 2018 Mar 16;8(1):4718. doi: 10.1038/s41598-018-23014-0.
9
Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study.非酒精性脂肪性肝病患者慢性肾脏病的发展：一项队列研究。
J Hepatol. 2017 Dec;67(6):1274-1280. doi: 10.1016/j.jhep.2017.08.024. Epub 2017 Sep 20.
10
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。
Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.
Zotero 插件